Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar 20;32(14):1553-60.
doi: 10.1016/j.vaccine.2013.08.066. Epub 2013 Sep 6.

Current status and prospects for development of an HSV vaccine

Christine Johnston  1 , David M Koelle  2 , Anna Wald  3
Affiliations

Current status and prospects for development of an HSV vaccine

Christine Johnston et al. Vaccine. .

Abstract

Herpes simplex virus type 2 (HSV-2) infects 530million people, is the leading cause of genital ulcer disease, and increases the risk of HIV-1 acquisition. Although several candidate vaccines have been promising in animal models, prophylactic and therapeutic vaccines have not been effective in clinical trials thus far. Null results from the most recent prophylactic glycoprotein D2 subunit vaccine trial suggest that we must reevaluate our approach to HSV-2 vaccine development. We discuss HSV-2 pathogenesis, immunity, and vaccine efforts to date, as well as the current pipeline of candidate vaccines and design of trials to evaluate new vaccine constructs.

Keywords: Genital herpes; Herpes simplex virus; Vaccine.

PubMed Disclaimer

References

    1. Looker KJ, Garnett GP, Schmid GP. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ. 2008;86:805–12. A. - PMC - PubMed
    1. Owusu-Edusei KJ, Chesson HW, Gift TL, Tao G, Mahajan R, Ocfemia MCB, et al. The Estimated Direct Medical Cost of Selected Sexually Transmitted Infections in the United States, 2008. Sexually Transmitted Diseases. 2013;40:197–201. 10.1097/OLQ.0b013e318285c6d2. - PubMed
    1. Center for Disease Control and Prevention Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years--United States, 2005-2008. MMWR Morb Mortal Wkly Rep. 2010;59:456–9. - PubMed
    1. Paz-Bailey G, Ramaswamy M, Hawkes SJ, Geretti AM. Herpes simplex virus type 2: epidemiology and management options in developing countries. Sexually Transmitted Infections. 2007;83:16–22. - PMC - PubMed
    1. Watson-Jones D, Weiss HA, Rusizoka M, Baisley K, Mugeye K, Changalucha J, et al. Risk factors for herpes simplex virus type 2 and HIV among women at high risk in northwestern Tanzania: preparing for an HSV-2 intervention trial. J Acquir Immune Defic Syndr. 2007;46:631–42. - PMC - PubMed

Publication types

MeSH terms

Substances